RT Journal Article SR Electronic T1 An Introduction to Newer PET Diagnostic Agents and Related Therapeutic Radiopharmaceuticals JF Journal of Nuclear Medicine Technology JO J. Nucl. Med. Technol. FD Society of Nuclear Medicine SP 203 OP 209 DO 10.2967/jnmt.118.224022 VO 47 IS 3 A1 Mantel, Ellie A1 Williams, Jessica YR 2019 UL http://tech.snmjournals.org/content/47/3/203.abstract AB With new radiopharmaceuticals constantly in development, the field of nuclear medicine is ever evolving. This continuing education article reviews some of the newer, less frequently used radiopharmaceuticals for PET diagnostic imaging and related therapeutic protocols. The radiopharmaceuticals discussed include U.S. Food and Drug Administration–approved tracers as well as tracers that are in clinical trials and have yet to obtain Food and Drug Administration approval. This article contains straightforward information on each tracer discussed, including disease process imaged or treated, half-life, energy, primary uses, basic protocols, distribution, and side effects. Although not all tracers may be available in rural locations, this information can be helpful in determining future patient-care offerings.